C3 and complement 3 glomerulopathy: In Cfh−/− mice (a model of C3 glomerulopathy, a kidney disease caused by the AP dysregulation), the ablation of C5 improves survival and reduces glomerular inflammation (mediated by C5a), but does not reduce proteinuria or glomerular C3 staining (95).